Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Better Therapeutics, Inc.BTTX · Entity 94385 | Director | December 18, 2023 | December 20, 2023 |
| Cigna GroupCI · Entity 550 | Director | April 23, 2025 | April 25, 2025 |
| DLH Holdings Corp.DLHC · Entity 7088 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Better Therapeutics, Inc.
Report date December 18, 2023 · Filed December 20, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,601 |
Reported balance
After 2023-12-18 transaction · row 1
1 source rowRow 1 · 2023-12-18 · Grant · Acquired 3,750 · Balance 39,601 F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
Cigna Group
Report date April 23, 2025 · Filed April 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 6,109 |
Reported balance
After 2025-04-23 transaction · row 1
1 source rowRow 1 · 2025-04-23 · Grant · Acquired 638 · Balance 6,109 |
DLH Holdings Corp.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 170,252 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 17,119 · Balance 170,252 F1: Grant of restricted stock units pursuant to the Company's 2025 Equity Incentive Plan, as amended. The award vests in full on September 30, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units pursuant to the Company's 2025 Equity Incentive Plan, as amended. The award vests in full on September 30, 2027.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CERNER Corp
Report date June 07, 2022 · Filed June 09, 2022
Section 16 reporting ended · disclosed 2022-06-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-06-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-06-07 · Other · Disposed 2,768 · Balance 5,403 F1: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. Row 2 · 2022-06-08 · Disposition to issuer · Disposed 5,403 · Balance 0 F2: This Form 4 reports securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each issued and outstanding share of Cerner common stock was cancelled and converted into the right to receive $95.00 per share in cash, without interest thereon and subject to any required tax withholding. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer.
F2: This Form 4 reports securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each issued and outstanding share of Cerner common stock was cancelled and converted into the right to receive $95.00 per share in cash, without interest thereon and subject to any required tax withholding.
Express Scripts Holding Co.
Report date December 20, 2018 · Filed December 21, 2018
Section 16 reporting ended · disclosed 2018-12-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 1
1 source rowRow 1 · 2018-12-20 · Disposition to issuer · Disposed 6,523 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.08 · Expires 2025-05-06 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-12-20 · Disposition to issuer · Disposed 3,222 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.74 · Expires 2026-05-04 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-12-20 · Disposition to issuer · Disposed 7,032 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.66 · Expires 2027-05-11 | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-12-20 · Disposition to issuer · Disposed 8,006 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement.
F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 22:00 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 17,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-065099 · wk-form4_1791237600.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,252 F1 · security: Grant of restricted stock units pursuant to the Company's 2025 Equity Incentive Plan, as amended. The award vests in full on September 30, 2027. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:54 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 10,941 | $0.00 | $0.00 |
DisclosureSEC source: 0000785557-25-000135 · wk-form4_1759438482.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,133 F1 · security: Grant of restricted stock units pursuant to the Company's 2025 Equity Incentive Plan. The award vests in full on September 30, 2026. Read SEC document |
| April 23, 2025 Filed Apr 25, 2025 20:32 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004422 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,109 Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 21:06 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,376 | $0.00 Strike: $151.48 | $0.00 |
DisclosureSEC source: 0001225208-25-003437 · doc4.xml · derivative · entry 3 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 2,376 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024. F2 · derivative.exercise_date: These stock options were granted on May 4, 2016 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 21:06 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 2,376 | $310.35 | $737,391.60 |
DisclosureSEC source: 0001225208-25-003437 · doc4.xml · nonDerivative · entry 2 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,471 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024. Read SEC document |
| March 14, 2025 Filed Mar 17, 2025 21:06 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 2,376 | $151.48 | $359,913.15 |
DisclosureSEC source: 0001225208-25-003437 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2024. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 21:23 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 10,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-041964 · wk-form4_1727904225.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,192 F1 · security: Grant of restricted stock units pursuant to the Company 2016 Omnibus Equity Incentive Plan. The award vests in full on September 30, 2025. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 10:01 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 547 | $0.00 Strike: $175.09 | $0.00 |
DisclosureSEC source: 0001225208-24-006915 · doc4.xml · derivative · entry 3 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 547 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F2 · derivative.exercise_date: These stock options were granted on May 6, 2015 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 10:01 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 547 | $331.38 | $181,264.86 |
DisclosureSEC source: 0001225208-24-006915 · doc4.xml · nonDerivative · entry 2 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,471 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 10:01 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 547 | $175.09 | $95,776.31 |
DisclosureSEC source: 0001225208-24-006915 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 21:35 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $175.09 | $0.00 |
DisclosureSEC source: 0001225208-24-006818 · doc4.xml · derivative · entry 3 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 547 Underlying: Common Stock, $.01 Par Value · 1,000 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F2 · derivative.exercise_date: These stock options were granted on May 6, 2015 and were fully vested at the closing of acquisition of Express Scripts Holding Company on December 20, 2018. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 21:35 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 1,000 | $338.08 | $338,080.00 |
DisclosureSEC source: 0001225208-24-006818 · doc4.xml · nonDerivative · entry 2 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,471 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 21:35 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 1,000 | $175.09 | $175,093.80 |
DisclosureSEC source: 0001225208-24-006818 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 21:14 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 539 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005287 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,471 Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 17:15 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-071942 · ownership.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,601 F1 · shares: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024. Read SEC document |
| October 01, 2023 Filed Oct 3, 2023 20:17 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 8,569 | $0.00 | $0.00 |
DisclosureSEC source: 0000785557-23-000070 · wk-form4_1696364245.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,251 F1 · security: Grant of restricted stock units pursuant to the Company's 2016 Omnibus Equity Incentive Plan. The award vests in full on September 30, 2024 Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 07:58 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | PurchaseCommon Stock | 34,251 | $0.73 | $24,999.80 |
DisclosureSEC source: 0000950170-23-035681 · ownership.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,851 F1 · kind: On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share. F2 · kind: As one of the PIPE Investors, the Reporting Person acquired 34,251 shares of Issuer common stock on July 27, 2023 for $0.7299 per share. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 18:56 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0000950170-23-027337 · ownership.xml · derivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023. Read SEC document |
| May 16, 2023 Filed May 18, 2023 07:11 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | PurchaseCommon Stock | 600 | $0.87 | $520.32 |
DisclosureSEC source: 0000950170-23-022874 · ownership.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600 Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 21:10 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 765 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005161 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,932 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 23:23 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 322 | $271.67 | $87,477.74 |
DisclosureSEC source: 0001225208-23-003871 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,167 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2023. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 00:52 UTC | Cigna Group CI · Entity 550 | GiftCommon Stock, $.01 Par Value | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001581 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,489 Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 20:05 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 8,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000785557-22-000028 · wf-form4_166491392020975.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,682 F1 · security: Grant of restricted stock units pursuant to the Company's 2016 Omnibus Equity Incentive Plan. The award vests in full on September 30, 2023. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 16:43 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0000899243-22-021942 · doc4.xml · derivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 9, 2022. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:25 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerCommon Stock | 5,403 | $95.00 | $513,285.00 |
DisclosureSEC source: 0001209191-22-035498 · doc4.xml · nonDerivative · entry 2 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: This Form 4 reports securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each issued and outstanding share of Cerner common stock was cancelled and converted into the right to receive $95.00 per share in cash, without interest thereon and subject to any required tax withholding. F2 · price: This Form 4 reports securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each issued and outstanding share of Cerner common stock was cancelled and converted into the right to receive $95.00 per share in cash, without interest thereon and subject to any required tax withholding. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 17:25 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 2,768 | $95.00 | $262,960.00 |
DisclosureSEC source: 0001209191-22-035498 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,403 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:11 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 757 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006307 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,689 Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 01:06 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 199 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003933 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,932 Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 16:23 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | PurchaseCommon Stock | 1,000 | $6.66 | $6,660.00 |
DisclosureSEC source: 0000899243-21-047110 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:35 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014393 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,733 Read SEC document |
| November 10, 2021 Filed Nov 15, 2021 17:17 UTC | Better Therapeutics, Inc. BTTX · Entity 94385 | GrantStock Option (Right to Buy) · Derivative | 28,300 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0000899243-21-044618 · doc4.xml · derivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,300 Underlying: Common Stock · 28,300 shares Expires 2031-11-09 F1 · derivative.exercise_date: The stock option vests as to 1/3 of the shares subject to the stock option on November 10, 2022 and the remaining shares vest in 24 equal monthly installments thereafter; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Issuer or otherwise ceases to serve as a director of the Issuer prior to any such vesting date. The stock option shall accelerate pursuant to the terms of the Non-Employee Director Compensation Policy of the Issuer. The stock option was granted on November 10, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:16 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0000785557-21-000015 · wf-form4_163346498114934.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,532 F1 · security: Grant of restricted stock units pursuant to the Company's 2016 Omnibus Equity Incentive Plan. The award vests in full on September 30, 2022. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011980 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,486 Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 01:01 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,844 | $0.00 Strike: $126.32 | $0.00 |
DisclosureSEC source: 0001225208-21-009634 · doc4.xml · derivative · entry 5 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 3,844 shares Expires 2027-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021. F3 · derivative.exercise_date: These stock options were granted on May 11, 2017 and were fully vested at the closing of acquisition of Express Scripts Holding Company on December 20, 2018. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 01:01 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $151.48 | $0.00 |
DisclosureSEC source: 0001225208-21-009634 · doc4.xml · derivative · entry 4 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,376 Underlying: Common Stock, $.01 Par Value · 1,000 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021. F2 · derivative.exercise_date: These stock options were granted on May 4, 2016 and were fully vested at the closing of acquisition of Express Scripts Holding Company on December 20, 2018. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 01:01 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 4,844 | $237.06 | $1,148,318.64 |
DisclosureSEC source: 0001225208-21-009634 · doc4.xml · nonDerivative · entry 3 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,262 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 01:01 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 1,000 | $151.48 | $151,478.60 |
DisclosureSEC source: 0001225208-21-009634 · doc4.xml · nonDerivative · entry 2 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 01:01 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 3,844 | $126.32 | $485,583.31 |
DisclosureSEC source: 0001225208-21-009634 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 21:12 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-008828 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,262 Read SEC document |
| May 19, 2021 Filed May 20, 2021 17:32 UTC | CERNER Corp CERN · Entity 126375 | GrantCommon Stock | 3,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034521 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,171 F1 · shares: These shares represent an award of restricted common stock that will vest on the earlier of May 25, 2022 or the calendar day immediately preceding the date of the Cerner Corporation 2022 annual meeting of shareholders. F2 · balance_after: Includes 6,510 shares of restricted common stock. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:30 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 226 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004291 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,079 Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 22:33 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 227 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-014150 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,853 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 09:10 UTC | CERNER Corp CERN · Entity 126375 | GrantCommon Stock | 1,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058968 · doc4.xml · nonDerivative · entry 2 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,983 F3 · shares: These shares represent an award of restricted common stock that will vest on the earlier of May 18, 2021 or the calendar day immediately preceding the date of the Cerner Corporation 2021 annual meeting of shareholders. F4 · balance_after: Includes 4,983 shares of restricted common stock. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 09:10 UTC | CERNER Corp CERN · Entity 126375 | GrantCommon Stock | 3,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058968 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,322 F1 · shares: These shares represent an award of restricted common stock that will vest per the following schedule: 1,107 on 11/16/2021, 1,107 on 11/16/2022 and 1,108 on 11/16/2023. F2 · balance_after: Includes 3,322 shares of restricted common stock. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:15 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 8,784 | $0.00 | $0.00 |
DisclosureSEC source: 0000785557-20-000006 · wf-form4_160192891478624.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,100 F1 · security: Grant of restricted stock units pursuant to the Company's 2016 Omnibus Equity Incentive Plan. The award vests in full on September 30, 2021. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 21:35 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 267 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011218 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,626 Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:06 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-008484 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,359 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:06 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 259 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-004180 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,119 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:41 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 237 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015088 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,860 Read SEC document |
| November 07, 2019 Filed Nov 12, 2019 21:24 UTC | DLH Holdings Corp. DLHC · Entity 7088 | GrantCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-013988 · wf-form4_157359382464975.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,316 F1 · security: Grant of restricted stock units pursuant to the Company's 2016 Omnibus Equity Incentive Plan. The award vests in full on September 30, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.